David Johnson
Director/Board Member en CARIBOU BIOSCIENCES, INC. .
Fortuna: - $ al 31/03/2024
Perfil
David L.
Johnson is currently an Independent Director at Caribou Biosciences, Inc. He previously worked as the Vice President-Sales & Marketing at Gilead Sciences, Inc. from 2003 to 2018 and as the Chief Commercial Officer at Global Blood Therapeutics, Inc. from 2018 to 2022.
Mr. Johnson completed his undergraduate degree at the University of Puget Sound and holds an MBA from Kenan-Flagler Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de David Johnson
| Empresas | Cargo | Inicio |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 11/05/2022 |
Antiguos cargos conocidos de David Johnson.
| Empresas | Cargo | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2022 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01/01/2018 |
Formación de David Johnson.
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- David Johnson
